搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 天
on MSN
Breaking boundaries: Protein found at cell's edge also discovered in nucleus
A team of researchers at Åbo Akademi University in Finland made a surprising discovery. They found that Talin-1, a protein ...
AZoM on MSN
2 天
Dose-Dependent In Vitro Osteogenic Activity on Strontium-Decorated Polyetheretherketone
Sr incorporation in PEEK via a polydopamine coating improves osteogenic potential, promoting cell adhesion and mineralization ...
11 天
on MSN
New biomarkers to detect colorectal cancer found with AI and machine learning
Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of ...
EurekAlert!
11 天
Researchers make breakthrough in bioprinting functional human heart tissue
Researchers at University of Galway have developed a way of bioprinting tissues that change shape as a result of ...
4 天
on MSN
New numbering system standardizes protein domain comparison for better research
Adhesion G protein-coupled receptors (GPCRs) are a group of cell-surface sensors associated with many body functions and diseases. However, they are not yet sufficiently understood to be exploited for ...
9 天
First Breakthrough Study Highlights Superiority of MatriDerm in Wound Healing
PRNewswire Billerbeck [Germany] January 23 MedSkin Solutions Dr Suwelack AG is pleased to announce the publication of a new ...
imt.ie
8 天
Irish breakthrough brings scientists closer to functional ‘printed’ organs
Irish researchers have developed a way of bioprinting tissues that change shape as a result of cell-generated forces, in the ...
GlobalData on MSN
5 天
Innate Pharma doses first patient in Nectin-4 ADC trial
The Phase I trial will evaluate the safety and efficacy of the company’s drug which targets tumours whilst leaving normal ...
5 天
Innate Pharma doses first patient in IPH4502 study
Innate Pharma (IPHA) announced the first patient was dosed in its Phase 1 study, investigating the safety and tolerability of IPH4502, an ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈